ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Chong Kun Dang Pharmaceutical clinical trials

Also known as CKD.

The registry lists 299 studies whose lead sponsor is Chong Kun Dang Pharmaceutical. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2026.

Keep track of what changes. Save the Chong Kun Dang Pharmaceutical studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
218
Status unknown
63
Recruiting
9
Not yet recruiting
6
Active, not recruiting
2
Terminated
1

Phase

Phase 1
205
Phase 4
36
Phase 3
36
Phase 2
19

Where

Korea, Republic of
267
United States
4
Poland
2
Russian Federation
2
United Kingdom
2
Netherlands
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Chong Kun Dang Pharmaceutical.

  • Chong Kun Dang Pharmaceutical
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    299 studies

Focus areas

Conditions Chong Kun Dang Pharmaceutical leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Diabetes Mellitus, Type 257Hypertension46Dyslipidemias39Cardiovascular Diseases11Essential Hypertension11

Studies

Recruiting first, then most recently updated. Showing 50 of 299. Browse all 299 →